Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks - A prospective cohort study

被引:73
作者
Tanne, D
Koren-Morag, N
Goldbourt, U
机构
[1] Tel Aviv Univ, Sackler Sch Med, Div Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel
[2] Sheba Med Ctr, Neufeld Cardiac Res Inst, Tel Hashomer, Israel
[3] Sheba Med Ctr, Dept Neurol, Stroke Unit, Tel Hashomer, Israel
关键词
diabetes mellitus; glucose; risk factors; stroke; ischemic;
D O I
10.1161/01.STR.0000140738.94047.55
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Diabetes and impaired fasting glucose are diagnosed based on an elevated plasma glucose level after an overnight fast. The diagnostic cutpoint of diabetes arises from the threshold for development of microvascular complications. Our aim was to examine the associations between clinical relevant categories of fasting glucose levels and the risk of incident ischemic stroke. Methods-Patients with documented coronary heart disease who were screened for inclusion in a secondary prevention clinical trial (n = 13 999) were followed-up. At baseline, medical histories were obtained and plasma glucose and lipids assessed at a central study laboratory. During a 6- to 8-year follow-up period 1037 cases were identified with ischemic cerebrovascular disease, of which, after reviewing hospital records with diagnoses of cerebrovascular disease, 576 cases were verified to have had ischemic stroke or transient ischemic attacks. Results-Increasing fasting glucose level categories were positively associated with increasing age, male gender, body mass index, hypertension, total cholesterol, and triglycerides, and were inversely associated with high-density lipoprotein cholesterol and percent high-density lipoprotein of total cholesterol. In comparison with patients with fasting glucose levels of 90 to 99 mg/dL (n = 3706) who constitute the largest category, the odds ratios of ischemic cerebrovascular disease, adjusting for potential confounders, were 1.47 (95% CI, 1.07 to 2.02) for fasting glucose <80, 1.22 (0.98 to 1.52) for 80 to 89, 1.27 (1.02 to 1.60) for 100 to 109, 1.60 (1.26 to 2.03) for 110 to 125, 1.82 (1.33 to 2.49) for 126 to 140, and 2.82 (2.32 to 3.43) for > 140 mg/dL. Similar J-shaped associations were observed in analysis excluding patients with known diagnosis of diabetes mellitus. Conclusions-The association between fasting plasma glucose and incident ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease is J-shaped. Rates increase for fasting plasma glucose levels > 100 mg/dL and also for those with low fasting glucose levels. These findings may carry important implications for prevention strategies.
引用
收藏
页码:2351 / 2355
页数:5
相关论文
共 22 条
[1]   Fasting blood glucose: An underestimated risk factor for cardiovascular death - Results from a 22-year follow-up of healthy nondiabetic men [J].
Bjornholt, JV ;
Erikssen, G ;
Aaser, E ;
Sandvik, L ;
Nitter-Hauge, S ;
Jervell, J ;
Erikssen, J ;
Thaulow, E .
DIABETES CARE, 1999, 22 (01) :45-49
[2]   Risk factors for stroke in type 2 diabetes mellitus - United Kingdom prospective diabetes study (UKPDS) 29 [J].
Davis, TME ;
Millns, H ;
Stratton, IM ;
Holman, RR ;
Turner, RC .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1097-1103
[3]   Plasma glucose and prediction of microvascular disease and mortality - Evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes [J].
Gabir, MM ;
Hanson, RL ;
Dabelea, D ;
Imperatore, G ;
Roumain, J ;
Bennett, PH ;
Knowler, WC .
DIABETES CARE, 2000, 23 (08) :1113-1118
[4]   Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia [J].
Galassetti, P ;
Davis, SN .
CLINICAL SCIENCE, 2000, 99 (05) :351-362
[5]  
Gavin JR, 1999, DIABETES CARE, V22, pS5
[6]  
Genuth S, 2003, DIABETES CARE, V26, P3160
[7]  
Goldstein LB, 2001, CIRCULATION, V103, P163
[8]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[9]  
Howard BV, 2002, CIRCULATION, V105, pE128
[10]  
Qiao Q, 2003, DIABETES CARE, V26, P688